Myasthenia Gravis Drugs Market Trends, Forecast and Application to 2021 by Radiant Insights,Inc
The report, Global Myasthenia Gravis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
The report, Global Myasthenia Gravis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> <strong>Market</strong> Research<br />
Report <strong>to</strong> <strong>2021</strong><br />
“The report, Global <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> <strong>Market</strong><br />
2017-<strong>2021</strong>, has been prepared based on an in-depth<br />
market analysis with inputs from industry experts.<br />
The report covers the market l<strong>and</strong>scape <strong>and</strong> its<br />
growth prospects over the coming years.”<br />
Currently, the myasthenia gravis drugs market st<strong>and</strong>s at a small size due <strong>to</strong> limited availability of<br />
approved therapies for the complete remission of the disease. However, the anticipated approval of<br />
novel drugs such as monoclonal antibodies should help market witness strong growth during the<br />
forecast period. For instance, Alexion Pharmaceuticals is currently developing a monoclonal<br />
antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or<br />
beginning of 2018, this drug is expected <strong>to</strong> be the blockbuster drug for the market.<br />
The analysts forecast the global myasthenia gravis drugs market <strong>to</strong> grow at a CAGR of 13.16%<br />
during the period 2017-<strong>2021</strong>.<br />
Browse Full Research Report @:<br />
http://www.radiantinsights.com/research/global-myasthenia-gravis-drugs-market-<br />
2017-<strong>2021</strong><br />
Follow Us:
Covered in this report<br />
The report covers the present scenario <strong>and</strong> the growth prospects of the global myasthenia gravis<br />
drugs market for 2017-<strong>2021</strong>. To calculate the market size, the report considers the revenue<br />
generated from the sales of myasthenia gravis drugs.<br />
The market is divided in<strong>to</strong> the following segments based on geography:<br />
• Americas<br />
• APAC<br />
• EMEA<br />
The report, Global <strong>Myasthenia</strong> <strong>Gravis</strong> <strong>Drugs</strong> <strong>Market</strong> 2017-<strong>2021</strong>, has been prepared based on an indepth<br />
market analysis with inputs from industry experts. The report covers the market l<strong>and</strong>scape<br />
<strong>and</strong> its growth prospects over the coming years. The report also includes a discussion of the key<br />
vendors operating in this market.<br />
Request A Sample Copy of This Report at:<br />
http://www.radiantinsights.com/research/global-myasthenia-gravis-drugs-market-<br />
2017-<strong>2021</strong>/request-sample<br />
Key vendors<br />
• Flamel Technologies<br />
• F. Hoffmann-La Roche<br />
• Grifols<br />
• Pfizer<br />
• Shire<br />
• Valeant Pharmaceuticals<br />
Other prominent vendors<br />
• Alexion Pharmaceuticals<br />
• Catalyst Pharmaceuticals<br />
• CSL<br />
• Curavac<br />
• Cy<strong>to</strong>kinetics<br />
• Galencia<br />
• GlaxoSmithKline<br />
• Lupin Pharmaceuticals<br />
• Mitsubishi Tanabe Pharma<br />
• Novartis<br />
Follow Us:
<strong>Market</strong> driver<br />
• Approval of novel monoclonal antibodies<br />
• For a full, detailed list, view our report<br />
<strong>Market</strong> challenge<br />
• Limited availability of approved drugs<br />
• For a full, detailed list, view our report<br />
<strong>Market</strong> trend<br />
• Emergence of new entrants<br />
• For a full, detailed list, view our report<br />
Key questions answered in this report<br />
• What will the market size be in <strong>2021</strong> <strong>and</strong> what will the growth rate be?<br />
• What are the key market trends?<br />
• What is driving this market?<br />
• What are the challenges <strong>to</strong> market growth?<br />
• Who are the key vendors in this market space?<br />
• What are the market opportunities <strong>and</strong> threats faced <strong>by</strong> the key vendors?<br />
Table of Contents:<br />
1. Scope of the report<br />
2. <strong>Market</strong> research methodology<br />
3. Introduction<br />
4. Pipeline analysis<br />
5. <strong>Market</strong> l<strong>and</strong>scape<br />
6. <strong>Market</strong> segmentation <strong>by</strong> therapy area<br />
7. Geographical segmentation<br />
8. <strong>Market</strong> drivers<br />
9. Impact of drivers<br />
10.<strong>Market</strong> challenges<br />
11.Impact of drivers <strong>and</strong> challenges<br />
12.<strong>Market</strong> trends<br />
13.Vendor l<strong>and</strong>scape<br />
14.Key vendor analysis<br />
List of Exhibits:<br />
Exhibit 01: Product offerings<br />
Exhibit 02: Key cus<strong>to</strong>mer segments of global myasthenia gravis drugs market<br />
Exhibit 03: Fac<strong>to</strong>rs affecting the adoption rates of myasthenia gravis drugs market<br />
Follow Us:
Exhibit 04: Key pipeline c<strong>and</strong>idates<br />
Exhibit 05: Global myasthenia gravis drugs market snapshot<br />
Exhibit 06: Analysis of global myasthenia gravis drugs market<br />
Exhibit 07: Global myasthenia gravis drugs market 2016-<strong>2021</strong> ($ millions)<br />
Exhibit 08: Opportunity analysis of global myasthenia gravis drugs market<br />
Exhibit 09: Opportunity analysis in developed <strong>and</strong> emerging markets<br />
Exhibit 10: Five forces analysis<br />
Exhibit 11: Segmentation of global myasthenia gravis drugs market <strong>by</strong> therapy<br />
Exhibit 12: Segmentation of global myasthenia gravis drugs market based on geography<br />
2016 <strong>and</strong> <strong>2021</strong><br />
Exhibit 13: Global myasthenia gravis drugs market revenue <strong>by</strong> geography 2016-<strong>2021</strong> ($<br />
millions)<br />
Exhibit 14: <strong>Market</strong> scenario in Americas<br />
Exhibit 15: <strong>Myasthenia</strong> gravis drugs market in Americas 2016-<strong>2021</strong> ($ millions)<br />
Exhibit 16: <strong>Market</strong> scenario in EMEA<br />
Exhibit 17: <strong>Myasthenia</strong> gravis drugs market in EMEA 2016-<strong>2021</strong> ($ millions)<br />
Exhibit 18: <strong>Market</strong> scenario in APAC<br />
Exhibit 19: <strong>Myasthenia</strong> gravis drugs market in APAC 2016-<strong>2021</strong> ($ millions)<br />
Exhibit 20: Key drivers <strong>and</strong> challenges in APAC<br />
Exhibit 21: Key pipeline monoclonal antibodies<br />
Exhibit 22: <strong>Inc</strong>idence data for myasthenia gravis (annually)<br />
Exhibit 23: Impact of drivers<br />
Exhibit 24: Forcefield analysis of drivers <strong>and</strong> challenges<br />
Exhibit 25: Impact of drivers <strong>and</strong> challenges<br />
Exhibit 26: Key entrants in myasthenia gravis drugs market<br />
Exhibit 27: Key acquisitions <strong>and</strong> their impact<br />
Exhibit 28: Competitive structure analysis of global myasthenia gravis drugs market 2015<br />
Exhibit 29: Competitive analysis of global myasthenia gravis drugs market<br />
Exhibit 30: <strong>Market</strong> penetration of various myasthenia gravis manufacturers 2015<br />
Exhibit 31: Flamel Technologies: Key highlights<br />
See More Reports of This Category <strong>by</strong> <strong>Radiant</strong> <strong>Insights</strong>:<br />
http://www.radiantinsights.com/catalog/healthcare<br />
Follow Us:
About <strong>Radiant</strong> <strong>Insights</strong>,<strong>Inc</strong>:<br />
<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking <strong>to</strong> meet their market<br />
research <strong>and</strong> business intelligence requirements. We assist <strong>and</strong> facilitate<br />
organizations <strong>and</strong> individuals procure market research reports, helping them in<br />
the decision making process. We have a comprehensive collection of reports,<br />
covering over 40 key industries <strong>and</strong> a host of micro markets. In addition <strong>to</strong> over<br />
extensive database of reports, our experienced research coordina<strong>to</strong>rs also offer a<br />
host of ancillary services such as, research partnerships/ tie-ups <strong>and</strong> cus<strong>to</strong>mized<br />
research solutions.<br />
Contact Details:<br />
Michelle Thoras<br />
Corporate Sales Specialist, USA<br />
<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States<br />
Phone: 1-415-349-0054<br />
Toll Free: 1-888-202-9519<br />
Email: sales@radiantinsights.com<br />
Web: http://www.radiantinsights.com/<br />
Visit Our Blog: http://researchanalysisreports.blogspot.in/<br />
Follow Us:
Change language